With Limited Near-Term PFO Closure Prospects In U.S., NMT Looks To Europe
This article was originally published in The Gray Sheet
Executive Summary
NMT Medical is banking on strong market growth in Europe to counteract stagnant U.S. performance
You may also be interested in...
Earnings Roundup: Updates From Quarterly Business Reports
With earnings season in full swing, device firms are disclosing financial results and, in some cases, more details about their future plans. Here are highlights from earnings reports released during the past week
Earnings Roundup: Updates From Quarterly Business Reports
With earnings season in full swing, device firms are disclosing financial results and, in some cases, more details about their future plans. Here are highlights from earnings reports released during the past week
AGA Medical Pursues Stroke, Migraine Indications And $200 Mil. IPO
AGA Medical hopes to complete a pivotal U.S. trial by year-end assessing its Amplatzer PFO Occluder for prevention of recurrent cryptogenic strokes, the company says in a June 20 prospectus for a planned initial public offering worth up to $200 million